aer+ for OSA
Obstructive Sleep Apnea (OSA) and chronic snoring
Pivotal TrialActive
Key Facts
Indication
Obstructive Sleep Apnea (OSA) and chronic snoring
Phase
Pivotal Trial
Status
Active
Company
About Sommetrics
Sommetrics is a clinical-stage medical device company targeting the massive, underserved global sleep apnea market. The company's lead platform, aer+ technology, represents a novel, non-invasive approach to treating airway narrowing by applying negative external pressure (vacuum) via a soft collar worn around the neck. This mechanism of action is fundamentally different from positive pressure (CPAP) or implantable devices, potentially offering a more comfortable and compliant solution. Sommetrics is advancing its lead product through a pivotal clinical trial (SUPRA study) and has an FDA-cleared acute care product, aerFree, being commercialized by a separate entity.
View full company profile